3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Conditions
Liver Neoplasms
1
Hemorrhage
1
Colorectal Neoplasms
1
Blood Loss, Surgical
1
Interventions
Oxaliplatin
1004
Fluorouracil
800
Capecitabine
764
Gemcitabine
650
Leucovorin
559
Irinotecan
537
Bevacizumab
513
Radiotherapy
460
Cisplatin
440
Drug Therapy
298
Cetuximab
280
Surgical Procedures, Operative
229
Paclitaxel
228
S 1 (combination)
217
pembrolizumab
205
Docetaxel
199
130-nm albumin-bound paclitaxel
196
Nivolumab
193
sintilimab
191
Radiosurgery
190
lenvatinib
180
Folfox protocol
179
Sorafenib
178
Albumin-Bound Paclitaxel
173
apatinib
170
tislelizumab
161
camrelizumab
160
Neoadjuvant Therapy
158
Blood Specimen Collection
154
durvalumab
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Neuromuscular Blockade
×
Gastrointestinal
×
Clear all
NCT04609410
2025-08-07
MODELS
Università Vita-Salute San Raffaele
Phase NA
Terminated
48 enrolled
NCT02327494
2015-01-07
OXYMUBLOC
Hospital Universitari de Bellvitge
Unknown
70 enrolled